Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,680   10.61  Index Moved Up 0.64%
FNMFO FNMFO 096770 KDDIF Hybrid Mix Electronics Emerging Markets Beers 
United States GSPC USD ...  |  Check Insiders


Processing
Collecting data for QRXPY

QRxPharma discussions

 
 Companies |  Insiders  | Dashboard  
  
Add To Portfolio  add QRXPY.PK to portfolio
   

QRxPharma Pty

Stock@OTC Market 
United States 
     
Use QRxPharma Pty Ltd discussions together with your other otc stock asset holdings to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.  Optimize Portfolio
       

QRxPharma discussions

       
       

Currently Trending  

 PRPFX 
 NAS United States 
 Bought over 50 shares of  Permanent Portfolio
 19 minutes ago
for 47.73 
 VT 
 PCX United States 
 Bought few shares of  Vanguard Total World Stock Ind
 20 minutes ago
for 55.52 
 FSLXX 
 ASE United States 
 Sold over 10K shares of  Fidelity Select Portfolios Mon
 22 minutes ago
for 1.0 
 FCONX 
 NAS United States 
 Bought over 10K shares of  Fidelity Conservative Income B
 26 minutes ago
for 10.04 
 RYOCX 
 NAS United States 
 Bought over 10K shares of  Rydex NASDAQ100 Inv
 27 minutes ago
for 19.76 
 FSHOX 
 NAS United States 
 Bought over 100 shares of  Fidelity Select Construction
 28 minutes ago
for 57.74 
       
Chance of
Bankruptcy
Less
Than
43%
In The Next
Two Years
?
QRxPharma Pty Ltd has less than 43.147 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Check Z Score
View Details
Follow QRxPharma Discussions with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
Get Widget
 
Add QRxPharma to your reader
Syndicate
 

QRxPharma Research Report

   
Generate Report

QRxPharma vs. Federal

Correlation analysis and fundamentals comparison between QRxPharma Pty and Federal National Mor
Correlation
Fundamentals

Compare QRxPharma To

Federal  Federal  096770  KDDI  Japan  Inpex  AP M  AP M  Citigroup  Akbank 
 Risk & Return  Correlation

QRxPharma Selected Financial Ratios

Current Ratio vs One Year Low
Cash Flow from Operations vs Return On Asset
Current Ratio vs EBITDA
Earnings Per Share vs Return On Asset
Current Ratio vs Return On Equity
Cash and Equivalents vs Return On Asset
Current Ratio vs Current Valuation
Cash per Share vs Return On Asset
 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
Take our survey
  
Financial Widget
Financial Widgets
Financial Content
Investing Content
Get Stock Ticker
Stock Tickers
 
Opportunities   Themes   Suggestions
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
  © 2013 Macroaxis Inc. All rights reserved       Custom Reporting   Advertising   Mobile Access   Retirement Grader   Alpha Search   Compare Stocks
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium